BillionToOne, Inc. (NASDAQ: BLLN) Stock Competitors & Peer Comparison
See BLLN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BLLN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BLLN | $93.33 | -0.75% | 4.3B | 133.33 | $0.70 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.71% |
| TMO | $588.29 | -1.28% | 218.5B | 25.39 | $23.16 | +0.30% |
| DHR | $202.45 | -0.71% | 142.3B | 25.37 | $7.98 | +0.71% |
| NTRA | $309.93 | -0.27% | 44.4B | -194.92 | -$1.59 | N/A |
| IDXX | $550.96 | -2.82% | 43.5B | 38.75 | $14.22 | N/A |
| A | $148.53 | -0.51% | 42B | 25.57 | $5.81 | +0.68% |
| IQV | $236.66 | -2.01% | 39B | 19.52 | $12.13 | N/A |
| WAT | $412.17 | -0.32% | 30.8B | 30.12 | $13.68 | N/A |
| ILMN | $190.89 | -0.91% | 28.9B | 37.95 | $5.03 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
BLLN vs DHR-PB Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, BLLN's ROE is +0.08%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, BLLN is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
BLLN vs TMO Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, TMO has a market cap of 218.5B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while TMO trades at $588.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas TMO's P/E ratio is 25.39. In terms of profitability, BLLN's ROE is +0.08%, compared to TMO's ROE of +0.13%. Regarding short-term risk, BLLN is more volatile compared to TMO. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
BLLN vs DHR Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, DHR has a market cap of 142.3B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while DHR trades at $202.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas DHR's P/E ratio is 25.37. In terms of profitability, BLLN's ROE is +0.08%, compared to DHR's ROE of +0.08%. Regarding short-term risk, BLLN is more volatile compared to DHR. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check DHR's competition here
Natera, Inc. (NASDAQ: NTRA)
BLLN vs NTRA Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, NTRA has a market cap of 44.4B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while NTRA trades at $309.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas NTRA's P/E ratio is -194.92. In terms of profitability, BLLN's ROE is +0.08%, compared to NTRA's ROE of -0.12%. Regarding short-term risk, BLLN is more volatile compared to NTRA. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check NTRA's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
BLLN vs IDXX Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, IDXX has a market cap of 43.5B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while IDXX trades at $550.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas IDXX's P/E ratio is 38.75. In terms of profitability, BLLN's ROE is +0.08%, compared to IDXX's ROE of +0.72%. Regarding short-term risk, BLLN is more volatile compared to IDXX. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check IDXX's competition here
Agilent Technologies, Inc. (NYSE: A)
BLLN vs A Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, A has a market cap of 42B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while A trades at $148.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas A's P/E ratio is 25.57. In terms of profitability, BLLN's ROE is +0.08%, compared to A's ROE of +0.21%. Regarding short-term risk, BLLN is more volatile compared to A. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check A's competition here
IQVIA Holdings Inc. (NYSE: IQV)
BLLN vs IQV Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, IQV has a market cap of 39B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while IQV trades at $236.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas IQV's P/E ratio is 19.52. In terms of profitability, BLLN's ROE is +0.08%, compared to IQV's ROE of +0.22%. Regarding short-term risk, BLLN is more volatile compared to IQV. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check IQV's competition here
Waters Corporation (NYSE: WAT)
BLLN vs WAT Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, WAT has a market cap of 30.8B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while WAT trades at $412.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas WAT's P/E ratio is 30.12. In terms of profitability, BLLN's ROE is +0.08%, compared to WAT's ROE of +0.02%. Regarding short-term risk, BLLN is more volatile compared to WAT. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check WAT's competition here
Illumina, Inc. (NASDAQ: ILMN)
BLLN vs ILMN Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, ILMN has a market cap of 28.9B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while ILMN trades at $190.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas ILMN's P/E ratio is 37.95. In terms of profitability, BLLN's ROE is +0.08%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, BLLN is more volatile compared to ILMN. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check ILMN's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
BLLN vs MTD Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, MTD has a market cap of 28.7B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while MTD trades at $1,419.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas MTD's P/E ratio is 32.61. In terms of profitability, BLLN's ROE is +0.08%, compared to MTD's ROE of -12.00%. Regarding short-term risk, BLLN is more volatile compared to MTD. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check MTD's competition here
Labcorp Holdings Inc. (NYSE: LH)
BLLN vs LH Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, LH has a market cap of 26.1B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while LH trades at $318.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas LH's P/E ratio is 18.87. In terms of profitability, BLLN's ROE is +0.08%, compared to LH's ROE of +0.12%. Regarding short-term risk, BLLN is more volatile compared to LH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check LH's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
BLLN vs DGX Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, DGX has a market cap of 26.1B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while DGX trades at $234.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas DGX's P/E ratio is 23.29. In terms of profitability, BLLN's ROE is +0.08%, compared to DGX's ROE of +0.14%. Regarding short-term risk, BLLN is more volatile compared to DGX. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check DGX's competition here
Guardant Health, Inc. (NASDAQ: GH)
BLLN vs GH Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, GH has a market cap of 21.1B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while GH trades at $157.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas GH's P/E ratio is -60.93. In terms of profitability, BLLN's ROE is +0.08%, compared to GH's ROE of +2.11%. Regarding short-term risk, BLLN is more volatile compared to GH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
BLLN vs EXAS Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas EXAS's P/E ratio is -95.37. In terms of profitability, BLLN's ROE is +0.08%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, BLLN is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check EXAS's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
BLLN vs ILMNV Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas ILMNV's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.08%, compared to ILMNV's ROE of N/A. Regarding short-term risk, BLLN is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check ILMNV's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
BLLN vs MEDP Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, MEDP has a market cap of 16.1B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while MEDP trades at $578.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas MEDP's P/E ratio is 33.91. In terms of profitability, BLLN's ROE is +0.08%, compared to MEDP's ROE of +1.10%. Regarding short-term risk, BLLN is more volatile compared to MEDP. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check MEDP's competition here
PerkinElmer, Inc. (NYSE: PKI)
BLLN vs PKI Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas PKI's P/E ratio is 41.45. In terms of profitability, BLLN's ROE is +0.08%, compared to PKI's ROE of +0.03%. Regarding short-term risk, BLLN is more volatile compared to PKI. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PKI's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
BLLN vs CRL Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, CRL has a market cap of 13.5B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while CRL trades at $280.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas CRL's P/E ratio is 28.29. In terms of profitability, BLLN's ROE is +0.08%, compared to CRL's ROE of -0.08%. Regarding short-term risk, BLLN is more volatile compared to CRL. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CRL's competition here
Revvity, Inc. (NYSE: RVTY)
BLLN vs RVTY Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, RVTY has a market cap of 13B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while RVTY trades at $116.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas RVTY's P/E ratio is 21.83. In terms of profitability, BLLN's ROE is +0.08%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, BLLN is more volatile compared to RVTY. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check RVTY's competition here
ICON Public Limited Company (NASDAQ: ICLR)
BLLN vs ICLR Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, ICLR has a market cap of 12.5B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while ICLR trades at $163.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas ICLR's P/E ratio is 13.31. In terms of profitability, BLLN's ROE is +0.08%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, BLLN is more volatile compared to ICLR. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check ICLR's competition here
Qiagen N.V. (NYSE: QGEN)
BLLN vs QGEN Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, QGEN has a market cap of 8.9B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while QGEN trades at $42.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas QGEN's P/E ratio is 17.76. In terms of profitability, BLLN's ROE is +0.08%, compared to QGEN's ROE of +0.12%. Regarding short-term risk, BLLN is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check QGEN's competition here
Twist Bioscience Corporation (NASDAQ: TWST)
BLLN vs TWST Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, TWST has a market cap of 7.4B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while TWST trades at $118.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas TWST's P/E ratio is -53.41. In terms of profitability, BLLN's ROE is +0.08%, compared to TWST's ROE of -0.30%. Regarding short-term risk, BLLN is less volatile compared to TWST. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check TWST's competition here
RadNet, Inc. (NASDAQ: RDNT)
BLLN vs RDNT Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, RDNT has a market cap of 6B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while RDNT trades at $76.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas RDNT's P/E ratio is 165.98. In terms of profitability, BLLN's ROE is +0.08%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, BLLN is more volatile compared to RDNT. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check RDNT's competition here
Sotera Health Company (NASDAQ: SHC)
BLLN vs SHC Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, SHC has a market cap of 5.4B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while SHC trades at $18.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas SHC's P/E ratio is 19.68. In terms of profitability, BLLN's ROE is +0.08%, compared to SHC's ROE of +0.27%. Regarding short-term risk, BLLN is more volatile compared to SHC. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check SHC's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
BLLN vs SYNH Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas SYNH's P/E ratio is 61.40. In terms of profitability, BLLN's ROE is +0.08%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, BLLN is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check SYNH's competition here
Veracyte, Inc. (NASDAQ: VCYT)
BLLN vs VCYT Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, VCYT has a market cap of 3.3B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while VCYT trades at $41.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas VCYT's P/E ratio is 20.63. In terms of profitability, BLLN's ROE is +0.08%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, BLLN is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check VCYT's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
BLLN vs OLK Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas OLK's P/E ratio is -96.59. In terms of profitability, BLLN's ROE is +0.08%, compared to OLK's ROE of -0.07%. Regarding short-term risk, BLLN is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check OLK's competition here
Neogen Corporation (NASDAQ: NEOG)
BLLN vs NEOG Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, NEOG has a market cap of 2.5B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while NEOG trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas NEOG's P/E ratio is 41.61. In terms of profitability, BLLN's ROE is +0.08%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, BLLN is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check NEOG's competition here
CareDx, Inc (NASDAQ: CDNA)
BLLN vs CDNA Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, CDNA has a market cap of 2.3B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while CDNA trades at $45.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas CDNA's P/E ratio is 53.95. In terms of profitability, BLLN's ROE is +0.08%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, BLLN is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check CDNA's competition here
Personalis, Inc. (NASDAQ: PSNL)
BLLN vs PSNL Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, PSNL has a market cap of 1.5B. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while PSNL trades at $14.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas PSNL's P/E ratio is -12.88. In terms of profitability, BLLN's ROE is +0.08%, compared to PSNL's ROE of -0.46%. Regarding short-term risk, BLLN is more volatile compared to PSNL. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PSNL's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
BLLN vs CSTL Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, CSTL has a market cap of 933.3M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while CSTL trades at $29.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas CSTL's P/E ratio is -69.43. In terms of profitability, BLLN's ROE is +0.08%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, BLLN is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check CSTL's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
BLLN vs GRALV Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas GRALV's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.08%, compared to GRALV's ROE of N/A. Regarding short-term risk, BLLN is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check GRALV's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
BLLN vs FLGT Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, FLGT has a market cap of 527.1M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while FLGT trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas FLGT's P/E ratio is 1856.00. In terms of profitability, BLLN's ROE is +0.08%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, BLLN is more volatile compared to FLGT. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check FLGT's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
BLLN vs NEO Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, NEO has a market cap of 409.6M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while NEO trades at $15.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas NEO's P/E ratio is 122.62. In terms of profitability, BLLN's ROE is +0.08%, compared to NEO's ROE of -0.06%. Regarding short-term risk, BLLN is more volatile compared to NEO. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check NEO's competition here
Global Cord Blood Corporation (NYSE: CO)
BLLN vs CO Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas CO's P/E ratio is 5.06. In terms of profitability, BLLN's ROE is +0.08%, compared to CO's ROE of +0.11%. Regarding short-term risk, BLLN is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check CO's competition here
Prenetics Global Limited (NASDAQ: PRE)
BLLN vs PRE Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, PRE has a market cap of 335.8M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while PRE trades at $19.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas PRE's P/E ratio is -9.59. In terms of profitability, BLLN's ROE is +0.08%, compared to PRE's ROE of -0.47%. Regarding short-term risk, BLLN is less volatile compared to PRE. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check PRE's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
BLLN vs FLDM Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas FLDM's P/E ratio is -4.74. In terms of profitability, BLLN's ROE is +0.08%, compared to FLDM's ROE of +0.18%. Regarding short-term risk, BLLN is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check FLDM's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
BLLN vs MYGN Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, MYGN has a market cap of 286.2M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while MYGN trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas MYGN's P/E ratio is -23.31. In terms of profitability, BLLN's ROE is +0.08%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, BLLN is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check MYGN's competition here
Prenetics Global Limited (NASDAQ: PRENW)
BLLN vs PRENW Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, PRENW has a market cap of 262.7M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas PRENW's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.08%, compared to PRENW's ROE of -0.47%. Regarding short-term risk, BLLN is less volatile compared to PRENW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check PRENW's competition here
Trinity Biotech plc (NASDAQ: TRIB)
BLLN vs TRIB Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, TRIB has a market cap of 236.3M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while TRIB trades at $11.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas TRIB's P/E ratio is -0.19. In terms of profitability, BLLN's ROE is +0.08%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, BLLN is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check TRIB's competition here
Biodesix, Inc. (NASDAQ: BDSX)
BLLN vs BDSX Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, BDSX has a market cap of 195.4M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while BDSX trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas BDSX's P/E ratio is -7.57. In terms of profitability, BLLN's ROE is +0.08%, compared to BDSX's ROE of -7.88%. Regarding short-term risk, BLLN is more volatile compared to BDSX. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check BDSX's competition here
Exagen Inc. (NASDAQ: XGN)
BLLN vs XGN Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, XGN has a market cap of 160.9M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while XGN trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas XGN's P/E ratio is -9.65. In terms of profitability, BLLN's ROE is +0.08%, compared to XGN's ROE of -1.22%. Regarding short-term risk, BLLN is more volatile compared to XGN. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check XGN's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
BLLN vs IMDX Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, IMDX has a market cap of 139.5M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while IMDX trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas IMDX's P/E ratio is -3.63. In terms of profitability, BLLN's ROE is +0.08%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, BLLN is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check IMDX's competition here
Genetron Holdings Limited (NASDAQ: GTH)
BLLN vs GTH Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas GTH's P/E ratio is -1.11. In terms of profitability, BLLN's ROE is +0.08%, compared to GTH's ROE of -1.01%. Regarding short-term risk, BLLN is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
BLLN vs GENE Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas GENE's P/E ratio is -38.25. In terms of profitability, BLLN's ROE is +0.08%, compared to GENE's ROE of -1.85%. Regarding short-term risk, BLLN is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check GENE's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
BLLN vs SERA Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, SERA has a market cap of 74.9M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while SERA trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas SERA's P/E ratio is -3.02. In terms of profitability, BLLN's ROE is +0.08%, compared to SERA's ROE of -0.47%. Regarding short-term risk, BLLN is less volatile compared to SERA. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check SERA's competition here
Atlantic International Corp. (NASDAQ: ATLN)
BLLN vs ATLN Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas ATLN's P/E ratio is -0.68. In terms of profitability, BLLN's ROE is +0.08%, compared to ATLN's ROE of +14.94%. Regarding short-term risk, BLLN is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check ATLN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
BLLN vs DRIO Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, DRIO has a market cap of 53.6M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while DRIO trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas DRIO's P/E ratio is -1.25. In terms of profitability, BLLN's ROE is +0.08%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, BLLN is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check DRIO's competition here
Precipio, Inc. (NASDAQ: PRPO)
BLLN vs PRPO Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, PRPO has a market cap of 41.9M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while PRPO trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas PRPO's P/E ratio is -90.38. In terms of profitability, BLLN's ROE is +0.08%, compared to PRPO's ROE of -0.07%. Regarding short-term risk, BLLN is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check PRPO's competition here
MDxHealth S.A. (NASDAQ: MDXH)
BLLN vs MDXH Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, MDXH has a market cap of 41.5M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while MDXH trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas MDXH's P/E ratio is -2.13. In terms of profitability, BLLN's ROE is +0.08%, compared to MDXH's ROE of +4.03%. Regarding short-term risk, BLLN is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check MDXH's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
BLLN vs QUCY Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, QUCY has a market cap of 33.6M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while QUCY trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas QUCY's P/E ratio is -0.07. In terms of profitability, BLLN's ROE is +0.08%, compared to QUCY's ROE of -3.26%. Regarding short-term risk, BLLN is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check QUCY's competition here
Akumin Inc. (NASDAQ: AKU)
BLLN vs AKU Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas AKU's P/E ratio is -0.13. In terms of profitability, BLLN's ROE is +0.08%, compared to AKU's ROE of -5.32%. Regarding short-term risk, BLLN is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check AKU's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
BLLN vs CEMI Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas CEMI's P/E ratio is -0.63. In terms of profitability, BLLN's ROE is +0.08%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, BLLN is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
BLLN vs ENZ Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas ENZ's P/E ratio is -2.24. In terms of profitability, BLLN's ROE is +0.08%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, BLLN is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
BLLN vs PMD Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas PMD's P/E ratio is -5.24. In terms of profitability, BLLN's ROE is +0.08%, compared to PMD's ROE of -0.32%. Regarding short-term risk, BLLN is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
BLLN vs ME Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas ME's P/E ratio is -0.03. In terms of profitability, BLLN's ROE is +0.08%, compared to ME's ROE of -42.03%. Regarding short-term risk, BLLN is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
BLLN vs MYNZ Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, BLLN's ROE is +0.08%, compared to MYNZ's ROE of -1.80%. Regarding short-term risk, BLLN is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check MYNZ's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
BLLN vs BNGO Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, BNGO has a market cap of 13.5M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while BNGO trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas BNGO's P/E ratio is -0.27. In terms of profitability, BLLN's ROE is +0.08%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, BLLN is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BNGO's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
BLLN vs ADVB Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, ADVB has a market cap of 12.4M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while ADVB trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas ADVB's P/E ratio is -81.36. In terms of profitability, BLLN's ROE is +0.08%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, BLLN is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check ADVB's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
BLLN vs CHEK Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas CHEK's P/E ratio is -0.43. In terms of profitability, BLLN's ROE is +0.08%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, BLLN is less volatile compared to CHEK. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check CHEK's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
BLLN vs BNR Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, BNR has a market cap of 9.5M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while BNR trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas BNR's P/E ratio is -11.00. In terms of profitability, BLLN's ROE is +0.08%, compared to BNR's ROE of -0.11%. Regarding short-term risk, BLLN is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BNR's competition here
Centogene N.V. (NASDAQ: CNTG)
BLLN vs CNTG Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas CNTG's P/E ratio is -0.23. In terms of profitability, BLLN's ROE is +0.08%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, BLLN is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check CNTG's competition here
Check-Cap Ltd. Ordinary Share (NASDAQ: MBAI)
BLLN vs MBAI Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, MBAI has a market cap of 8.7M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while MBAI trades at $8.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas MBAI's P/E ratio is 13.01. In terms of profitability, BLLN's ROE is +0.08%, compared to MBAI's ROE of +4.17%. Regarding short-term risk, BLLN is less volatile compared to MBAI. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check MBAI's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
BLLN vs APDN Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas APDN's P/E ratio is -0.10. In terms of profitability, BLLN's ROE is +0.08%, compared to APDN's ROE of -7.23%. Regarding short-term risk, BLLN is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check APDN's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
BLLN vs NDRA Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, NDRA has a market cap of 5.7M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while NDRA trades at $4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas NDRA's P/E ratio is -0.57. In terms of profitability, BLLN's ROE is +0.08%, compared to NDRA's ROE of -5.13%. Regarding short-term risk, BLLN is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check NDRA's competition here
Invitae Corporation (NYSE: NVTA)
BLLN vs NVTA Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas NVTA's P/E ratio is -0.00. In terms of profitability, BLLN's ROE is +0.08%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, BLLN is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDX)
BLLN vs LMDX Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas LMDX's P/E ratio is -0.01. In terms of profitability, BLLN's ROE is +0.08%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, BLLN is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check LMDX's competition here
LumiraDx Limited (NASDAQ: LMDXW)
BLLN vs LMDXW Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, BLLN's ROE is +0.08%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, BLLN is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check LMDXW's competition here
DermTech, Inc. (NASDAQ: DMTK)
BLLN vs DMTK Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas DMTK's P/E ratio is -0.04. In terms of profitability, BLLN's ROE is +0.08%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, BLLN is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check DMTK's competition here
Inotiv, Inc. (NASDAQ: NOTV)
BLLN vs NOTV Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas NOTV's P/E ratio is -0.03. In terms of profitability, BLLN's ROE is +0.08%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, BLLN is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check NOTV's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
BLLN vs BIAF Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, BIAF has a market cap of 2.5M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while BIAF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas BIAF's P/E ratio is -0.05. In terms of profitability, BLLN's ROE is +0.08%, compared to BIAF's ROE of -2.57%. Regarding short-term risk, BLLN is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BIAF's competition here
SeqLL Inc. (NASDAQ: SQL)
BLLN vs SQL Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas SQL's P/E ratio is -0.40. In terms of profitability, BLLN's ROE is +0.08%, compared to SQL's ROE of +38.02%. Regarding short-term risk, BLLN is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
BLLN vs AWH Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas AWH's P/E ratio is -0.09. In terms of profitability, BLLN's ROE is +0.08%, compared to AWH's ROE of +2.03%. Regarding short-term risk, BLLN is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check AWH's competition here
Intelligent Bio Solutions Inc. (NASDAQ: INBS)
BLLN vs INBS Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, INBS has a market cap of 1.8M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while INBS trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas INBS's P/E ratio is -0.33. In terms of profitability, BLLN's ROE is +0.08%, compared to INBS's ROE of -1.74%. Regarding short-term risk, BLLN is less volatile compared to INBS. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check INBS's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
BLLN vs HTGM Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas HTGM's P/E ratio is -0.03. In terms of profitability, BLLN's ROE is +0.08%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, BLLN is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
BLLN vs BIOC Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas BIOC's P/E ratio is -0.01. In terms of profitability, BLLN's ROE is +0.08%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, BLLN is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BIOC's competition here
iSpecimen Inc. (NASDAQ: ISPC)
BLLN vs ISPC Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, ISPC has a market cap of 312.4K. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while ISPC trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas ISPC's P/E ratio is -0.07. In terms of profitability, BLLN's ROE is +0.08%, compared to ISPC's ROE of -5.85%. Regarding short-term risk, BLLN is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check ISPC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
BLLN vs SQLLW Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, BLLN's ROE is +0.08%, compared to SQLLW's ROE of +38.02%. Regarding short-term risk, BLLN is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check SQLLW's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
BLLN vs OCDX Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas OCDX's P/E ratio is -42.28. In terms of profitability, BLLN's ROE is +0.08%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, BLLN is more volatile compared to OCDX. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check OCDX's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
BLLN vs CHEKZ Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.08%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, BLLN is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check CHEKZ's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
BLLN vs PRXL Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas PRXL's P/E ratio is 42.97. In terms of profitability, BLLN's ROE is +0.08%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, BLLN is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check PRXL's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
BLLN vs NDRAW Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas NDRAW's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.08%, compared to NDRAW's ROE of -5.13%. Regarding short-term risk, BLLN is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check NDRAW's competition here
Danaher Corporation (NYSE: DHR-PA)
BLLN vs DHR-PA Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, BLLN's ROE is +0.08%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, BLLN is more volatile compared to DHR-PA. This indicates higher risk in terms of short-term price fluctuations for BLLN.Check DHR-PA's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
BLLN vs MEUSW Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas MEUSW's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.08%, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, BLLN is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check MEUSW's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
BLLN vs BNGOW Comparison August 2026
BillionToOne, Inc. (NASDAQ: BLLN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BLLN stands at 4.3B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, BLLN is priced at $93.33 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BLLN currently has a P/E ratio of 133.33, whereas BNGOW's P/E ratio is N/A. In terms of profitability, BLLN's ROE is +0.08%, compared to BNGOW's ROE of -0.79%. Regarding short-term risk, BLLN is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for BLLN.Check BNGOW's competition here